These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32746954)

  • 21. Implicit factors influencing the HTA deliberative processes in 5 European countries: results from a mixed-methods research.
    Monleón C; Martin-Späth H; Crespo C; Dussart C; Toumi M
    Health Policy Open; 2023 Dec; 5():100109. PubMed ID: 38073709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
    Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.
    Frønsdal KB; Facey K; Klemp M; Norderhaug IN; Mørland B; Røttingen JA
    Int J Technol Assess Health Care; 2010 Jul; 26(3):309-16. PubMed ID: 20584360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Health technology assessment for decision-making in Latin America: good practice principles].
    Pichon-Riviere A; Soto NC; Augustovski FA; García Martí S; Sampietro-Colom L
    Rev Panam Salud Publica; 2018 Feb; 41():e138. PubMed ID: 29466522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The link between health technology assessment and decision making for the allocation of health resources in Latin America.
    Pichon-Riviere A; Augustovski F; García Martí S; Alfie V; Sampietro-Colom L
    Int J Technol Assess Health Care; 2020 Apr; 36(2):173-178. PubMed ID: 32312340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment.
    Trowman R; Migliore A; Ollendorf DA
    Int J Technol Assess Health Care; 2023 Feb; 39(1):e15. PubMed ID: 36815310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HEALTH TECHNOLOGY ASSESSMENT FOR DECISION MAKING IN LATIN AMERICA: GOOD PRACTICE PRINCIPLES.
    Pichon-Riviere A; Soto NC; Augustovski FA; García Martí S; Sampietro-Colom L
    Int J Technol Assess Health Care; 2018 Jan; 34(3):241-247. PubMed ID: 29888696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reinforcing Science and Policy, With Suggestions for Future Research Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Culyer AJ
    Int J Health Policy Manag; 2023; 12():7398. PubMed ID: 35942975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Evidence-Informed Deliberative Processes - Learning by Doing Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Culyer AJ
    Int J Health Policy Manag; 2020 Jun; 9(6):263-265. PubMed ID: 32613796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    Gopinathan U
    Int J Health Policy Manag; 2023; 12():7541. PubMed ID: 37579471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
    Schlander M
    Int J Health Policy Manag; 2021 Mar; 10(3):158-161. PubMed ID: 32610783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide".
    DiStefano MJ
    Int J Health Policy Manag; 2023; 12():7480. PubMed ID: 37579447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blueprint for a deliberative public forum on biobanking policy: were theoretical principles achievable in practice?
    Molster C; Maxwell S; Youngs L; Kyne G; Hope F; Dawkins H; O'Leary P
    Health Expect; 2013 Jun; 16(2):211-24. PubMed ID: 21645188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES.
    Daniels N; van der Wilt GJ
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):10-5. PubMed ID: 27472157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America.
    Pichon-Riviere A; Augustovski F; García Martí S; Alcaraz A; Alfie V; Sampietro-Colom L
    Int J Technol Assess Health Care; 2021 Aug; 37(1):e80. PubMed ID: 34392842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
    Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
    Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
    ; Neumann PJ; Drummond MF; Jönsson B; Luce BR; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2010 Jan; 26(1):71-8. PubMed ID: 20059783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.